Global Dental Hub connects industry professionals, enterprises, and innovators to drive worldwide advancements in oral healthcare. Access verified company profiles, uncover cross-border opportunities, and leverage real-time market intelligence—all designed to accelerate the globalization of dental innovation. Join us in shaping a connected future for the industry.
Pharmaceuticals (psychotropic and anesthetic drugs, morphine-based raw materials with 14 exclusive products via Qinghai Pharmaceutical Factory); Medical devices (oral equipment and consumables including Meijia/Mega denture products covering teeth treatment series, teeth beauty series, and auxiliary equipment; Basic Implant systems with advanced surface treatment and bone healing materials); Medical services (sports medicine, musculoskeletal rehabilitation, and orthopedic disease treatment through Hejia Sports Rehabilitation Center chain).
Kaisa Health Group Holdings Limited is a comprehensive platform dedicated to building China's large health industry, responsible for the investment, financing, operation, and management of the health sector businesses under the Kaisa Group. The group owns one Hong Kong-listed company (stock code: 00876.HK) and one main board-listed company in China (stock code: 000403.SZ), with core businesses spanning pharmaceuticals, medical devices, and medical services. Leveraging rare pharmaceutical licenses and strategic acquisitions, Kaisa Health has established a strong presence in psychotropic and anesthetic drugs through Qinghai Pharmaceutical Factory, the only domestic producer of morphine-based raw materials in China, which holds 14 exclusive drugs in this category. In the medical devices sector, the group has grown into one of the largest professional suppliers of oral equipment and consumables by acquiring Meijia Medical (also known as Mega Medical), a leading player recognized as one of the world's top four denture companies, Asia's first listed denture enterprise, and the owner of China's top "Mei Ya" denture brand, whose products cover approximately 90% of denture categories. Furthermore, the acquisition of U.S.-based Basic Implant brings advanced FDA and CFDA-qualified implant systems with clinically validated overseas performance, cutting-edge material technology, exclusive national-leading surface treatment processes, and unique materials that promote superior bone healing at world-advanced levels. In medical services, Kaisa Health operates the Hejia Sports Rehabilitation Center, a branded chain of medical institutions focused on sports medicine, musculoskeletal rehabilitation, and treatment of orthopedic-related diseases, serving sports enthusiasts, orthopedic patients, post-surgery individuals, and sub-health populations. With an extensive sales and service network across the United States, Germany, and more than 20 countries and regions, Kaisa Health emphasizes innovation in medical technology, integration of high-quality domestic and international resources, and penetration across the entire industry chain from upstream to downstream. Guided by the philosophy of providing personalized, high-quality medical products and services, the group continuously enhances its capabilities in research and development, production, and sales while actively laying out clinics and hospitals to become a leading force in China's oral medical industry and broader health sector.
Address：Room 3810, Block A, Tianxia Jinniu Center, No. 79 Taoyuan Road, Nanshan District, Shenzhen, China.
Telephone： Click to get in touch
Email： Click to get in touch
Website：https://www.kaisahealth.com
Joining Date：2026-03-31 21:00:27
Countries and Regions：
Total page views：140
Want to start a conversation about cooperation? Click the cooperation consultation button above to explore cooperation opportunities together.
